Securinol A is primarily studied for its potential neuroprotective properties, particularly in relation to neurodegenerative conditions such as Alzheimer’s disease. It has shown the ability to modulate key enzymes involved in neuronal survival and cognitive function. Research indicates it may enhance synaptic plasticity and support memory retention by influencing signaling pathways related to brain-derived neurotrophic factor (BDNF). Due to its natural origin and observed low toxicity in preliminary studies, Securinol A is considered a candidate for development in cognitive enhancers and therapeutic agents targeting age-related cognitive decline. Most current applications remain in the preclinical research phase, focusing on in vitro and animal models to evaluate efficacy and mechanism of action.